Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA01 - Improving Outcomes in Locoregional NSCLC I
- 10:30 - 12:00
- 9/24/2018
- Location: Room 107
- Type: Oral Abstract Session
- Track: Treatment of Locoregional Disease - NSCLC
-
+
OA01.05 - Phase II Study of Neo-Adjuvant Chemo/Immunotherapy for Resectable Stages IIIA Non-Small Cell Lung Cancer- Nadim Study-SLCG
11:15 - 11:25 | Presenter: Mariano Provencio | Author(s): Ernest Nadal, Amelia Insa, Rosario García Campelo, Gerardo Huidobro, Manuel Domine, Margarita Majem, Delvys Rodríguez-Abreu, Virginia Calvo, Alex Martinez-Marti, Javier De Castro, Manuel Cobo Dols, Guillermo Lopez-Vivanco, Elvira Del Barco, Reyes Bernabé, Nuria Vinolas, Isidoro Barneto, Bartomeu Massuti
- Abstract
Loading...
-
+
OA05 - Clinical Trials in IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Advanced NSCLC
-
+
OA05.07 - IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC
14:35 - 14:45 | Presenter: Vassiliki A Papadimitrakopoulou | Author(s): Manuel Cobo, Rodolfo Bordoni, Pascale Dubray-Longeras, Zsuzsanna Szalai, Grigoriy Ursol, Silvia Novello, Francisco Orlandi, Simon Ball, Jerome Goldschmidt Jr., Rachel E Sanborn, Tien Hoang, Diana Mendus, Yu Deng, Marcin Kowanetz, Xiaohui Wen, Wei Lin, Alan Sandler, Makoto Nishio
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-70 - Efficacy and Safety of Second- or Third-Line Nab-Paclitaxel + Durvalumab in Patients with Advanced NSCLC (ABOUND.2L+)
16:45 - 18:00 | Presenter: Daniel Morgensztern | Author(s): Ramaswamy Govindan, Manuel Cobo, Santiago Ponce Aix, Pieter E. Postmus, Conrad Lewanski, Jaafar Bennouna, Juergen R. Fischer, Óscar Juan-Vidal, David J Stewart, Andrea Ardizzoni, Rafia Bhore, Marianne Wolfsteiner, Martin Reck, Denis Talbot, Teng Jin Ong
- Abstract
Loading... -
+
P1.01-93 - Quality of Life in Patients with Advanced NSCLC Treated in Second- or Third-Line with Nab-Paclitaxel + Durvalumab: ABOUND.2L+
16:45 - 18:00 | Presenter: Santiago Ponce Aix | Author(s): Denis Talbot, Ramaswamy Govindan, Manuel Cobo, Pieter E. Postmus, Conrad Lewanski, Jaafar Bennouna, Juergen R. Fischer, Óscar Juan-Vidal, David J Stewart, Andrea Ardizzoni, Rafia Bhore, Marianne Wolfsteiner, Martin Reck, Daniel Morgensztern, Teng Jin Ong
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-01 - Anti-EGF Antibodies Increase the Effect of ALK and MEK Inhibitors in ALK and KRAS NSCLC and CRC Cell Lines
16:45 - 18:00 | Presenter: Silvia Garcia - Roman | Author(s): Jordi Codony-Servat, Miguel-Angel Molina-Vila, Jordi Bertran-Alamillo, Ana Giménez-Capitán, Santiago Viteri, Andrés F. Cardona, Delvys Rodríguez-Abreu, Manuel Cobo Dols, Noemi Reguart, Niki Karachaliou, Erik D'Hondt, Rafael Rosell
- Abstract
Loading... -
+
P1.13-36 - Randomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Lecia Sequist | Author(s): Jhanelle Elaine Gray, Wael A Harb, Robert C. Doebele, Manuel R; Modiano, David Michael Jackman, Maria Quintos Baggstrom, Akin Atmaca, Enriqueta Felip, Mariano Provencio, Manuel Cobo Dols, Bambang Adiwijaya, Geoffrey Kuesters, Walid Kamoun, Karen Andreas, J Marc Pipas, Sergio Santillana, Byoung Chul Cho, Keunchil Park, Frances A Shepherd
- Abstract
Loading...
-
+
MA15 - Colliding Approaches - EGFR and Immunotherapy
- 13:30 - 15:00
- 9/25/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA15.03 - PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial
13:40 - 13:45 | Presenter: Suresh S. Ramalingam | Author(s): Helen Brown, Johan F. Vansteenkiste, Kazuhiko Nakagawa, Manuel Cobo Dols, Thomas John, Craig Barker, Alexander Kohlmann, Alexander Todd, Matilde Saggese, Juliann Chmielecki, Aleksandra Markovets
- Abstract
Loading...
-
+
P2.04 - Immunooncology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.04-24 - Nivolumab in the "Real World": Are the Results of Clinical Trials Reproducible?
16:45 - 18:00 | Presenter: Inmaculada Ramos García | Author(s): Amparo Sanchez Gastaldo, Isidoro Barneto, Pable Ayala, Miguel Berciano, Reyes Bernabé, Marta Robles, Ricardo Collado, Miriam Alonso, Teresa García, Manuel Cobo Dols, Jose Manuel Trigo
- Abstract
Loading...